Immune booster: donor NK cells aim to stop leukemia return after transplant
NCT ID NCT07256210
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This clinical trial tests whether infusions of donor natural killer (NK) cells, given before and after a stem cell transplant, can safely prevent leukemia from coming back in children and young adults with hard-to-treat acute leukemia. The study enrolls 15 patients aged 0 to 25 with chemorefractory or minimal residual disease positive leukemia. Researchers will monitor side effects and the maximum tolerated dose, as well as how well the treatment clears leukemia from the bone marrow.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Donor-derived natural killer (NK) cells
What this could lead to
If successful, this approach could reduce the risk of leukemia returning after a stem cell transplant, offering a better chance of long-term remission for patients with difficult-to-treat acute leukemia.
What could go wrong
This is a small, early-phase trial with only 15 participants, so results may not apply broadly. There is a risk of serious side effects like graft-versus-host disease or infusion reactions, and the treatment may not prevent relapse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology
RECRUITINGMoscow, 117997, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••